About ImpediMed
ImpediMed is a leading global medical technology company that designs and manufactures medical devices that employ bioimpedance spectroscopy (BIS) technology for use in the noninvasive clinical assessment and monitoring of fluid status and tissue composition in patients. We consistently drive innovation by directing our primary efforts toward addressing the specific challenges and devastating burden of secondary lymphedema with a focus on breast cancer-related lymphedema (BCRL). We are an Australian stock exchange listed company with operations in the United States, Europe, and Australia.
Our Mission
Improve long term patient outcomes by forging new standards of care.
Our Vision
Revolutionize care with fluid and body composition analytics, enhancing health outcomes through clinically validated, secure platform technology.
Our Values
At ImpediMed, we are CUSTOMER CENTRIC in how we INNOVATE and collaborate to address specific healthcare needs to be market leaders. We value EXCELLENCE, INTEGRITY, and ACCOUNTABILITY, empowering our team to reach their highest potential while making a meaningful impact on patient lives. We cultivate a supportive environment where employees thrive and GROW both personally and professionally.
